Proton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults
Nikhil Raj, Anshuman Pandey, Raja Roy, Manodeep Sen, Jyotsna Agarwal
Citation Information :
Raj N, Pandey A, Roy R, Sen M, Agarwal J. Proton Nuclear Magnetic Resonance (1H NMR) Metabolomics Study in Serum, Urine, and Cystic Fluid for Differentiating Fertility and Staging of Intra-abdominal Hydatid Cyst in Adults. Euroasian J Hepatogastroenterol 2024; 14 (1):30-34.
Background: Cystic echinococcosis (CE) is a parasitic zoonosis caused by the tapeworm Echinococcus granulosus. Over the past few years, a lot of research has been done on liver illnesses using metabolomics techniques to identify biomarkers which could identify the diseases in its early stages. The present study was done to explore biomarkers in serum, urine, and cystic fluid which would help in differentiating, staging, and assessing fertility of intra-abdominal hydatid cyst by using proton nuclear magnetic resonance (1H NMR) metabolomics.
Materials and methods: In the study, 28 subjects (16 cases and 12 controls) were enrolled. Staging of hydatid cysts was performed using ultrasonography. In patients complying with case and control definition, blood, urine, and cystic fluid were collected for complete blood count, urine culture, Echinococcus IgG enzyme-linked immunosorbent assay (ELISA), and metabolomic analysis. The 17, 15, and 11 metabolites in serum, urine, and cystic fluid samples were quantified, respectively, to differentiate between case and control group.
Results: In this study, we observed that there was a significant downregulation of succinate metabolite in urine samples of cases, down-regulation of five metabolites (isoleucine, valine, histidine, tyrosine and formate) and upregulation of alanine in cystic fluid of cases.
Conclusion: Current study demonstrates that metabolomics can be used non-invasively for rapid diagnosis of CE. This is one of the very few studies, which used1H NMR spectroscopy, to analyze the profile of metabolites in serum, urine, and cystic fluid in cases of CE and controls.
Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004;17(1):107–35. DOI: 10.1128/CMR.17.1.107-135.2004.
Bhutani N, Kajal P. Hepatic echinococcosis: A review. Ann Med Surg (Lond) 2018;36:99–105. DOI: 10.1016/j.amsu.2018.10.032.
Botezatu C, Mastalier B, Patrascu T. Hepatic hydatid cyst - Diagnose and treatment algorithm. J Med Life 2018;11(3):203–209. DOI: 10.25122/jml-2018-0045.
Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st Century. Clin Microbiol Rev 2019;32(2):e00075-18. DOI: 10.1128/CMR.00075-18.
Moro P, Schantz PM. Echinococcosis: A review. Int J Infect Dis 2009;13(2):125–133. DOI: 10.1016/j.ijid.2008.03.037.
WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 2003;85(2):253–261. DOI: 10.1016/s0001-706x(02)00223-1.
Smego RA Jr, Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 2005;9(2):69–76. DOI: 10.1016/j.ijid.2004.08.001.
McManus DP, Gray DJ, Zhang W, et al. Diagnosis, treatment, and management of echinococcosis. BMJ 2012;344:e3866. DOI: 10.1136/bmj.e3866.
Stojkovic M, Rosenberger KD, Steudle F, et al. Watch and wait management of inactive cystic echinococcosis – does the path to inactivity matter – analysis of a prospective patient cohort. PLoS Negl Trop Dis 2016;10:e0005243. DOI: 10.1371/journal.pntd.0005243.
Calame P, Weck M, Busse-Cote A, et al. Role of the radiologist in the diagnosis and management of the two forms of hepatic echinococcosis. Insights Imaging 2022;13(1):68. DOI: 10.1186/s13244-022-01190-y.
Zhang W, Li J, McManus DP. Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 2003;16(1):18–36. DOI: 10.1128/CMR.16.1.18-36.2003.
Beyoğlu D, Idle JR. Metabolomic and lipidomic biomarkers for premalignant liver disease diagnosis and therapy. Metabolites 2020;10(2):50. DOI: 10.3390/metabo10020050.
Lin C, Chen Z, Zhang L, et al. Deciphering the metabolic perturbation in hepatic alveolar echinococcosis: A1H NMR-based metabolomics study. Parasit Vectors 2019;12(1):300. DOI: 10.1186/s13071-019-3554-0.
Bai Z, Ma X, Yan R, et al. Metabolomic profiling of early inactive hepatic alveolar and cystic echinococcosis. Acta Trop 2023;242:106875. DOI: 10.1016/j.actatropica.2023.106875.
Ciftci TT, Yabanoglu-Ciftci S, Unal E, et al. Metabolomic profiling of active and inactive liver cystic echinococcosis. Acta Trop 2021;221:105985. DOI: 10.1016/j.actatropica.2021.105985.
Hosch W, Junghanss T, Stojkovic M, et al. Metabolic viability assessment of cystic echinococcosis using high-field1H MRS of cyst contents. NMR Biomed 2008;21(7):734–754. DOI: 10.1002/nbm.1252.
Nagana Gowda GA, Raftery D. NMR-based metabolomics. Adv Exp Med Biol 2021;1280:19–37. DOI: 10.1007/978-3-030-51652-9_2.
Van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): What is in a name and what isn't? Magn Reson Med 2011;65(4): 927–948. DOI: 10.1002/mrm.22761.
